Biohit Oyj B Stock Current Valuation
| BIOBV Stock | EUR 2.33 0.00 0.00% |
Valuation analysis of Biohit Oyj B helps investors to measure Biohit Oyj's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Biohit Oyj's price fluctuation is unstable at this time. Calculation of the real value of Biohit Oyj B is based on 3 months time horizon. Increasing Biohit Oyj's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biohit Oyj is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biohit Stock. However, Biohit Oyj's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.33 | Real 1.97 | Hype 2.33 |
The intrinsic value of Biohit Oyj's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Biohit Oyj's stock price.
Estimating the potential upside or downside of Biohit Oyj B helps investors to forecast how Biohit stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biohit Oyj more accurately as focusing exclusively on Biohit Oyj's fundamentals will not take into account other important factors: Biohit Oyj B Company Current Valuation Analysis
Biohit Oyj's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biohit Oyj Current Valuation | 20.88 M |
Most of Biohit Oyj's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biohit Oyj B is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Biohit Oyj B has a Current Valuation of 20.88 M. This is 99.85% lower than that of the Health Care Equipment & Supplies sector and 99.55% lower than that of the Health Care industry. The current valuation for all Finland stocks is 99.87% higher than that of the company.
Biohit Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biohit Oyj's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biohit Oyj could also be used in its relative valuation, which is a method of valuing Biohit Oyj by comparing valuation metrics of similar companies.Biohit Oyj is currently under evaluation in current valuation category among its peers.
Biohit Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 20.88 M | |||
| Shares Outstanding | 12.07 M | |||
| Shares Owned By Insiders | 47.13 % | |||
| Price To Earning | 11.00 X | |||
| Price To Book | 3.28 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 9.36 M | |||
| Gross Profit | 5.92 M | |||
| EBITDA | 693 K | |||
| Net Income | (1.5 M) | |||
| Cash And Equivalents | 9.38 M | |||
| Cash Per Share | 0.63 X | |||
| Total Debt | 59 K | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 7.79 X | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | (444 K) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 3.8 | |||
| Number Of Employees | 44 | |||
| Beta | 1.02 | |||
| Market Capitalization | 30.69 M | |||
| Total Asset | 9.61 M | |||
| Retained Earnings | 6 M | |||
| Working Capital | 8 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 1000 K | |||
| Net Asset | 9.61 M |
About Biohit Oyj Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biohit Oyj B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biohit Oyj using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biohit Oyj B based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biohit Stock
Biohit Oyj financial ratios help investors to determine whether Biohit Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biohit with respect to the benefits of owning Biohit Oyj security.